As a full-service CRO solely dedicated to biotech companies and small- to mid-sized pharma, we provide a truly unique solution.
Expertise in nearly 40 psychiatric and neurological disorders, and clinically trained neuroscience teams led by scientists and clinicians with extensive neuroscience experience.
PPD's Phase I Clinic conducts clinical studies to determine how new medicines act in the bodies of healthy volunteers.
PPD News and Events Media kit
Jonca Bull discusses the significant regulatory actions that have occurred in the rare disease space.
PharmaVOICE (October 2017)
In this article written by Katie Matys and Janine McKnight, the authors discuss how the right biomarker can make all the difference in a drug-development program.
Genetic Engineering & Biotechnology News (October 2017)
Radek Wasiak of Evidera comments on real-world evidence in part three of this three-part series.
Clinical Leader (September 2017)
Radek Wasiak of Evidera comments on real-world evidence in part two of this three-part series.
In this article written by Denise Moody, Tim King and Ranjit Bains, the authors review an FSP in which PPD reduced a client’s annual operational spend by assuming responsibility for clinical monitoring and site support.
Pharmaceutical Executive (September 2017)
Radek Wasiak of Evidera comments on real-world evidence in part one of this three-part series.
Read about Susan Atkinson, Ph.D., senior vice president of global biometrics, who was named to the 2017 PharmaVOICE 100 list of the most inspiring people in the life sciences industry.
PharmaVOICE (August 2017)
Tammy Jackson discusses the innovative application of CDISC SDTM standards in clinical trials.
CenterWatch Monthly (July 2017)
Alistair Davidson and Bill Wang analyze the potential impact of a series of regulatory changes and improvements on clinical development in China.
Regulatory Rapporteur (July 2017)
Jing Tu and Patrick Bennett discuss available approaches that can be used to assess key assay parameters for pharmacokinetic and biomarker ligand-binding assays.
Bioanalysis (July 2017)
We want to hear from you
Register in PPD's Database
© 2017 Pharmaceutical Product Development, LLC. All rights reserved.